NCT03738449View on ClinicalTrials.gov

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

January 18, 2019

Study Completion Date

January 24, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

CKD-387

Test drug

DRUG

D484

reference drug

Trial Locations (1)

03722

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY